YKYoshiaki Kiso

Yoshiaki Kiso

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yoshiaki Kiso has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Hidehito Mukai

    Laboratory of Peptide Science, Graduate School of Bio-Science, Nagahama Institute of Bio-Science and Technology, Nagahama, Shiga 526-0829, Japan

    2 shared publications
  • Akihiko Harada

    Laboratory of Peptide Science, Graduate School of Bio-Science, Nagahama Institute of Bio-Science and Technology, Nagahama, Shiga, 526-0829, Japan

    1 shared publication
  • Kaori Wakamatsu

    1 shared publication
  • Koki Tsutsumi

    Laboratory of Peptide Science, Graduate School of Bio-Science, Nagahama Institute of Bio-Science and Technology, Nagahama, Shiga, 526-0829, Japan

    1 shared publication
  • Kosuke Noguchi

    Laboratory of Peptide Science, Graduate School of Bio-Science, Nagahama Institute of Bio-Science and Technology, Nagahama, Shiga, 526-0829, Japan

    1 shared publication
  • Takayuki Marutani

    Laboratory of Peptide Science, Graduate School of Bio-Science, Nagahama Institute of Bio-Science and Technology, Nagahama, Shiga, 526-0829, Japan

    1 shared publication

Latest Publications

  • Mitochondrial protein-derived cryptides: Are endogenousN-formylated peptides including mitocryptide-2 components of mitochondrial damage-associated molecular patterns?

    by Takayuki Marutani, Tatsuya Hattori, Koki Tsutsumi, Yusuke Koike, Akihiko Harada, Kosuke Noguchi, Yoshiaki Kiso, Hidehito Mukai

    Recently, much attention has been paid to “non-classical” bioactive peptides, which are fragmented peptides simultaneously produced during maturation and degradation of various functional proteins. We identified many fragmented peptides derived from various mitochondrial proteins including mitocryptide-1 and mitocryptide-2 that efficiently activate neutrophils. These endogenous, functionally active, fragmented peptides are referred to as “cryptides”. Among them, mitocryptide-2 is an N-formylated cryptide cleaved from mitochondrial cytochrome b that is encoded in mitochondrial DNA. It is known that thirteen proteins encoded in mitochondrial DNA are translated in mitochondria as N-formylated forms, suggesting the existence of endogenous N-formylated peptides other than mitocryptide-2. Here we investigated the effects of N-formylated peptides presumably cleaved from mitochondrial DNA-encoded proteins other than cytochrome b on the functions of neutrophilic cells in order to elucidate possible regulation by endogenous N-formylated cryptides. Four N-formylated cryptides derived from cytochrome c oxidase subunit I and NADH dehydrogenase subunits 4, 5, and 6 among twelve peptides from mitochondrial DNA-encoded proteins, efficiently induced not only migration but also β-hexosaminidase release, which is an indicator of neutrophilic phagocytosis, in HL-60 cells differentiated into neutrophilic cells. These activities were comparable to or higher than those induced by mitocryptide-2. Although endogenous N-formylated peptides that are contained in mitochondrial damage-associated molecular patterns (DAMPs) have yet to be molecularly identified, they have been implicated in innate immunity. Thus, N-formylated cryptides including mitocryptide-2 are first-line candidates for the contents of mitochondrial DAMPs to promote innate immune responses.


    • 1 June 2010
      • Vol. 82  (6) , 524-32

    [Discovery of cryptides and their novel signaling pathways].

    by Hidehito Mukai, Yoshiaki Kiso, Kaori Wakamatsu